铁状态影响脐血巨核祖细胞对艾曲泊帕的体外反应
艾曲泊帕(ELT)既是促血小板生成药物又是铁螯合剂,体外对巨核细胞生成呈剂量依赖性双向作用:低浓度≤6 µM刺激,高浓度30 µM抑制分化与增殖。定向巨核祖细胞对ELT30的抑制更敏感,铁缺乏可减少CD41+细胞增殖并降低高浓度血小板生成素下巨核细胞产量约50%。
要点
- ELT低浓度≤6 µM刺激巨核细胞生成,高浓度30 µM抑制分化与增殖。
- ELT30的抑制可被增加培养铁逆转,提示铁螯合机制。
- 铁缺乏降低CD41+细胞对所有浓度ELT的增殖反应。
核心结论
- 铁缺乏可刺激巨核细胞生成的某些细胞和步骤,但也能限制定向巨核祖细胞的增殖。
- 铁缺乏的严重程度和促血小板生成刺激强度共同影响最终巨核细胞输出。
研究设计与样本
- 体外研究,使用脐血巨核祖细胞,比较不同浓度ELT及铁状态对巨核细胞生成的影响。
主要发现
- ELT≤6 µM刺激巨核细胞生成,30 µM抑制巨核细胞分化与增殖。
- ELT30的抑制效应可被其他铁螯合剂重现,并因培养中铁增加而逆转。
- 定向巨核祖细胞(CD34+/CD41+和CD34-/CD41+)较未分化祖细胞(CD34+/CD41-)对ELT30抑制更敏感,源于增殖减少和凋亡增加。
- 铁缺乏降低CD41+细胞对所有ELT浓度的增殖反应。
- 严重铁缺乏使高浓度血小板生成素下巨核细胞数量较铁充足培养减少约50%。
临床怎么用
- 临床使用ELT时需关注患者铁状态,铁缺乏可能影响巨核祖细胞对ELT的增殖反应。
- ELT高浓度对巨核细胞生成的抑制作用提示需关注剂量相关效应。
局限性
- 研究为体外实验,巨核细胞生成、铁缺乏与ELT刺激的临床相互关系尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Eltrombopag (ELT) is a thrombopoietic agent approved for immune thrombocytopenia and also a potent iron chelator. Here we found that ELT exhibited dose-dependent opposing effects on in vitro megakaryopoiesis: low concentrations (≤6 µM, ELT6) stimulated megakaryopoiesis, but high concentrations (30 µM, ELT30) suppressed megakaryocyte (MK) differentiation and proliferation. The suppressive effects of ELT30 were reproduced by other iron chelators, supporting iron chelation as a likely mechanism. During MK differentiation, committed MK progenitors (CD34+/CD41+ and CD34-/CD41+ cells) were significantly more sensitive than undifferentiated progenitors (CD34+/CD41- cells) to the suppressive effects of ELT30, which resulted from both decreased proliferation and increased apoptosis. The antiproliferative effects of ELT30 were reversed by increased iron in the culture, as were the proapoptotic effects when exposure to ELT30 was short. Because committed MK progenitors exhibited the highest proliferative rate and the highest sensitivity to iron chelation, we tested whether their iron status influenced their response to ELT during rapid cell expansion. In these studies, iron deficiency reduced the proliferation of CD41+ cells in response to all ELT concentrations. Severe iron deficiency also reduced the number of MKs generated in response to high thrombopoietin concentrations by ∼50%, compared with iron-replete cultures. Our findings support the hypothesis that although iron deficiency can stimulate certain cells and steps in megakaryopoiesis, it can also limit the proliferation of committed MK progenitors, with severity of iron deficiency and degree of thrombopoietic stimulation influencing the ultimate output. Further studies are needed to clarify how megakaryopoiesis, iron deficiency, and ELT stimulation are clinically interrelated.
引用
- Liu ZJ, Deschmann E, Ramsey HE, et al. Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro. Blood Adv. 2022. PMID: 34654056. doi:10.1182/bloodadvances.2021004207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。